TMEM97 and cancer: The sphingolipid levels in MCF-7, Adr-, and T47D breast cancer cell lines after applying S2R-specific agonists have been investigated to further understand the molecular mechanism by which S2R substances can cause morphological and apoptotic effects in various cancer cell lines [32].